The Library
Photoactive platinum(iv) complex conjugated to a cancer-cell-targeting cyclic peptide
Tools
Shi, Huayun, Wang, Qian, Venkatesh, Venkatesh, Feng, Guokai, Young, Lawrence S., Romero-Canelón, Isolda, Zeng, Musheng and Sadler, P. J. (2019) Photoactive platinum(iv) complex conjugated to a cancer-cell-targeting cyclic peptide. Dalton Transactions, 48 (24). pp. 8560-8564. doi:10.1039/c9dt00909d ISSN 1477-9226.
|
PDF
WRAP-photoactive-platinum(IV)-complex-conjugated-cancer-cell-targeting-cyclic-peptide-Sadler-2019.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution. Download (638Kb) | Preview |
|
PDF
ch-310519-wrap--dt-com-02-2019-000909_script.pdf - Accepted Version Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Download (480Kb) |
||
|
PDF
WRAP-supporting-information-2019.pdf - Supplemental Material - Requires a PDF viewer. Download (800Kb) | Preview |
Official URL: http://dx.doi.org/10.1039/c9dt00909d
Abstract
A conjugate of cancer-cell targeting cyclic disulphide non a-peptide c(CRWYDENAC) consisting of nine L-amino acids with the photoactive succinate platinum(IV)complex trans, trans-[Pt(N3)2(py)2(OH)(succinate)] (Pt-cP) has been synthesised and characterised. The conjugate was stable in dark, but released succinate–peptide and Pt(II) species upon irradiation with visible light, and formed photoproducts with guanine. Conjugate Pt-cP exhibited higher photocytotoxicity than parent complextrans, trans, trans-[Pt(N3)2(OH)2(py)2] (FM-190) towards cancer cells, including ovarian A2780, lung A549 and prostate PC3 human cancer cells upon irradiation with blue light (465 nm, 17.28 J cm−2) with IC50values of 2.8–22.4μM and the highest potency for A549 cells. Even though the dark cellular accumulation of Pt-cP in A2780 cells was lower than that of parent FM-190, Pt from Pt-cP accumulated in cancer cells upon irradiation to a level >3× higher than that fromFM-190. In addition, the cellular accumulation of Pt from Pt-cPwas enhanced ca. 47× after irradiation.
Item Type: | Journal Article | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subjects: | R Medicine > RM Therapeutics. Pharmacology | |||||||||||||||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Science > Chemistry | |||||||||||||||||||||
Library of Congress Subject Headings (LCSH): | Prodrugs, Cyclic peptides | |||||||||||||||||||||
Journal or Publication Title: | Dalton Transactions | |||||||||||||||||||||
Publisher: | Royal Society of Chemistry | |||||||||||||||||||||
ISSN: | 1477-9226 | |||||||||||||||||||||
Official Date: | 28 June 2019 | |||||||||||||||||||||
Dates: |
|
|||||||||||||||||||||
Volume: | 48 | |||||||||||||||||||||
Number: | 24 | |||||||||||||||||||||
Page Range: | pp. 8560-8564 | |||||||||||||||||||||
DOI: | 10.1039/c9dt00909d | |||||||||||||||||||||
Status: | Peer Reviewed | |||||||||||||||||||||
Publication Status: | Published | |||||||||||||||||||||
Access rights to Published version: | Open Access (Creative Commons) | |||||||||||||||||||||
Date of first compliant deposit: | 3 June 2019 | |||||||||||||||||||||
Date of first compliant Open Access: | 4 June 2019 | |||||||||||||||||||||
RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year